FEATURED ARTICLES
MORE FROM THIS ISSUE
InforMS: Winter 2020
The Importance of Early and Effective Treatment with DMTs
By Kerri Cechovic
The Rocky Mountain MS Center and our partners at the Rocky Mountain MS Center at University of Colorado advocate for a fundamental philosophy of maximizing lifelong brain health through early...
InforMS: Winter 2020
Modern Era of Approved MS Disease Modifying Therapies
By Rocky Mountain MS Center
A timeline of the FDA approval of various disease modifying therapies for multiple sclerosis. 1993 Interferon β-1b SQ (Betaseron®) 1996 Interferon β-1a IM (Avonex® ) 1996 Glatiramer acetate SQ (GA –...
InforMS: Winter 2020
Highly Effective Treatments with Good Risk/Benefit Ratios
By Rocky Mountain MS Center
Individualizing treatment according to a patient’s risk profile starting with high-efficacy treatments helps prevent irreversible brain and spinal cord damage, thus leading to better outcomes. First Line: Natalizumab (Tysabri) in JCV...
InforMS: Winter 2020
Patient Assistance Programs: A Vital Resource for Qualified Patients
By Rocky Mountain MS Center
It’s no secret that many of the most commonly-prescribed MS treatments can be expensive, making access to them difficult for some people living with MS. Understanding this, many pharmaceutical companies...
InforMS: Winter 2020
Changing How the World Treats MS
By Rocky Mountain MS Center
A Look at Current Research Priorities at the Rocky Mountain MS Center at University of Colorado The Rocky Mountain MS Center at University of Colorado is the home of one...
InforMS: Winter 2020
Empower MS: Building Resilience
By Kerri Cechovic
A Lifelong Practice for Coping with Stress and Anxiety As we reflect on the past year, some words and emotions are likely to surface for many of us right away:...
InforMS: Winter 2020
COVID-19 and MS: The Latest from the Rocky Mountain MS Center
By Peter Broderick
EDITOR’S NOTE: Information contained in this article is current as of the time of printing, Nov. 25, 2020. Despite months of precautions, warnings and official guidelines, the COVID-19 pandemic is...
InforMS: Winter 2020
Disease Modifying Therapies in MS
By Rocky Mountain MS Center
The following is a current chart of disease modifying therapies approved for the treatment of multiple sclerosis, as of November 2020. Reviewed by Rocky Mountain MS Center Medical Director Dr. Timothy...